141 related articles for article (PubMed ID: 19523464)
1. Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.
Kelley WE; Lockwood CM; Cervelli DR; Sterner J; Scott MG; Duh SH; Christenson RH
Clin Biochem; 2009 Sep; 42(13-14):1444-51. PubMed ID: 19523464
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
[TBL] [Abstract][Full Text] [Related]
3. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
[TBL] [Abstract][Full Text] [Related]
4. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study.
Macdonald SP; Nagree Y
Emerg Med Australas; 2008 Oct; 20(5):403-9. PubMed ID: 18973637
[TBL] [Abstract][Full Text] [Related]
5. Analytical performance of a sensitive assay for cardiac troponin I with loci technology.
Arrebola MM; Lillo JA; Diez De Los Ríos MJ; Rodríguez M; Dayaldasani A; Yahyaoui R; Pérez V
Clin Biochem; 2010 Aug; 43(12):998-1002. PubMed ID: 20444425
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems.
Lestin M; Hergert M; Lestin HG; Brinker C; Storm H; Kuhrt E; Kuhrt B; Lambrecht HG; Kühnel W
Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224
[TBL] [Abstract][Full Text] [Related]
7. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
8. Analytical performance of time-resolved fluorometry-based Innotrac Aio! cardiac marker immunoassays.
Hedberg P; Valkama J; Puukka M
Scand J Clin Lab Invest; 2003; 63(1):55-64. PubMed ID: 12729070
[TBL] [Abstract][Full Text] [Related]
9. Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure.
Lewandrowski K
Clin Lab Med; 2009 Sep; 29(3):561-71. PubMed ID: 19840688
[TBL] [Abstract][Full Text] [Related]
10. Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure.
Flores-Solís LM; Hernández-Domínguez JL; Otero-González A; González-Juanatey JR
Nefrologia; 2012; 32(6):809-18. PubMed ID: 23169364
[TBL] [Abstract][Full Text] [Related]
11. Impact of the troponin standard on the prevalence of acute myocardial infarction.
Kontos MC; Fritz LM; Anderson FP; Tatum JL; Ornato JP; Jesse RL
Am Heart J; 2003 Sep; 146(3):446-52. PubMed ID: 12947361
[TBL] [Abstract][Full Text] [Related]
12. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction.
Wu AH; Feng YJ; Contois JH; Pervaiz S
Ann Clin Lab Sci; 1996; 26(4):291-300. PubMed ID: 8800429
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction].
Xiao HG; Huang ZH; Liu HX; Lin YP
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):550-1. PubMed ID: 15897132
[TBL] [Abstract][Full Text] [Related]
14. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
15. Myocardial injury after off-pump coronary artery bypass grafting operation.
Paparella D; Cappabianca G; Malvindi P; Paramythiotis A; Galeone A; Veneziani N; Fondacone C; de Luca Tupputi Schinosa L
Eur J Cardiothorac Surg; 2007 Sep; 32(3):481-7. PubMed ID: 17643993
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
[TBL] [Abstract][Full Text] [Related]
17. Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department.
Jaffery Z; Nowak R; Khoury N; Tokarski G; Lanfear DE; Jacobsen G; McCord J
Am Heart J; 2008 Nov; 156(5):939-45. PubMed ID: 19061710
[TBL] [Abstract][Full Text] [Related]
18. Troponin T or troponin I or CK-MB (or none?).
Collinson PO
Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
[TBL] [Abstract][Full Text] [Related]
19. Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology.
Mion MM; Novello E; Altinier S; Rocco S; Zaninotto M; Plebani M
Clin Biochem; 2007 Nov; 40(16-17):1245-51. PubMed ID: 17894935
[TBL] [Abstract][Full Text] [Related]
20. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay.
Ecollan P; Collet JP; Boon G; Tanguy ML; Fievet ML; Haas R; Bertho N; Siami S; Hubert JC; Coriat P; Montalescot G
Int J Cardiol; 2007 Jul; 119(3):349-54. PubMed ID: 17097752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
